1. A Broad m6A Modification Landscape in Inflammatory Bowel Disease
   Kai Nie et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
2. Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission
   Zongwei Li et al, 2021, Frontiers in Nutrition CrossRef
3. Outlook on next-generation probiotics from the human gut
   Francesca De Filippis et al, 2022, Cellular and Molecular Life Sciences CrossRef
4. Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
   Kai Nie et al, 2021, Frontiers in Cellular and Infection Microbiology CrossRef
5. Cyberlindnera jadinii and Kluyveromyces lactis , two fungi used in food processes, have potential probiotic effects on gut inflammation
   Cindy Hugot et al, 2023, mSystems CrossRef
6. The influence of the gut microbiome on BCG-induced trained immunity
   Martin Stražar et al, 2021, Genome Biology CrossRef
7. Gut microbiota alternation under the intestinal epithelium-specific knockout of mouse Piga gene
   Aditi Jangid et al, 2022, Scientific Reports CrossRef
8. A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn’s Disease
   Kai Nie et al, 2022, Frontiers in Pharmacology CrossRef
9. Aqueous extract of Sargentodoxa cuneata alleviates ulcerative colitis and its associated liver injuries in mice through the modulation of intestinal flora and related metabolites
   Feng Xu et al, 2024, Frontiers in Microbiology CrossRef
10. Environmental and Human Microbiome for Health
    Bimala Panthee et al, 2022, Life CrossRef
11. A Polyclonal Aptamer Library for the Specific Binding of the Gut Bacterium Roseburia intestinalis in Mixtures with Other Gut Microbiome Bacteria and Human Stool Samples
    Hu Xing et al, 2022, International Journal of Molecular Sciences CrossRef
12. Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential “Next Generation Probiotic”
    Chao Zhang et al, 2022, Frontiers in Microbiology CrossRef
13. Cell-free probiotic supernatant (CFS) treatment alleviates indomethacin-induced enterocolopathy in BALB/c mice by down-modulating inflammatory response and oxidative stress: potential alternative targeted treatment
    Arezki Samer et al, 2022, Inflammopharmacology CrossRef
14. Gut microbiota, inflammatory bowel disease and colorectal cancer
    Ana Elisa Valencise Quaglio et al, 2022, World Journal of Gastroenterology CrossRef
15. Relationship between maternal–infant gut microbiota and infant food allergy
    Shuo Wang et al, 2022, Frontiers in Microbiology CrossRef